On top of this, the binding of PD-L1 to its target receptors spurs on cancer cell growth and survival pathways, potentially instigating epithelial-mesenchymal transition and conferring stem cell-like properties that fuel tumor advancement, as observed in cases of renal cancer (Zhou et al., 2023[129]). The gene discussed is CD274; the disease is cancer.